• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Analysis of substrates transport mechanism and structural modification of MRP1

Research Project

Project/Area Number 14570123
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionKagoshima University

Principal Investigator

FURUKAWA Tatsuhiko  Kagoshima University, Graduate School of Medical and Dental Sciences, Associate Professor, 大学院・医歯学総合研究科, 助教授 (40219100)

Project Period (FY) 2002 – 2003
KeywordsMRP1 / LTC_4 / photoaffinity labeling / glutathione / ABC transporter / nucleotide binding domain / trypsin digestion sites
Research Abstract

We previously reported azidoAG-A, a photoanalog of a novel MRP1 modulating agent agosterol-A(AG-A), can bind to C-terminal part of MRP1 in the presence of glutathione (GSH) and share the binding sites with other anti-cancer drugs.
We here analyzed binding sites of azidoAG-A more precisely.The molecular weight of the smallest photolabling fragment after trypsin digestion was l6kDa, which was derived from the cytoplasmic portion between TM15 and TM16 or TM17 and NDB2.We focused on charged amino acid residues arginine around TM16-17, since we found TM16-17 and cytoplasmic region up to1295 was essential for drug binding.
The point mutant of 1202th R could not be photolabeled with azidoAG-A, but had LTC4 transport activity.However, 1249R mutant could not be photolabeled and transport LTC4.Thus 1249R is essential for transport activity of MRP1.
The mechanisms of drug transportation and coupling with AlP hydrolysis, in particular the function of the signature sequences(ss)in the nucleotide binding domains(NBDs) of MRP1 are unknown.The effects of mutation of the signature sequences(G771D and G1433D)on the azido-ATP photolabeling and vanadate trapping were examined.The G771D mutation completely inhibited trapping at NBD2 and considerably inhibited trapping at NBD1.However, the G1433D mutation also considerably inhibited trap-ping at NBD1.Since either mutation decreased the transport activity of LTC4, both ss of MRP1 are involved in AlP hydrolysis and must be intact for the transport by MRP1.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Wang, X., 他: "Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors."Molecular Pharmacology. 63. 65-72 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikeda R: "Thymidine phosphorylase inihibits apoptosis induced cisplatin."Biochemica. et Biophysica. Research Communication. 301. 358-363 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ren XQ.: "Localization of the GSH-dependent photolablling site of an agosterol A anaolog on human MRP1"British Journal of Pharmacology. 138. 1553-1561 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mukai M: "Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562cells"Cancer Science. 94. 557-563 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mituso M: "Binding Site(s) on P-glycoprotein for a newly synthesized photoagginity analog of Agosterol A."Oncology Research. 14. 39-48 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakajima Y.: "Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-Deoxy-L-ribose"Cancer Research. 64. 1794-1801 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ren XQ: "The Functions of ABC Signature Sequence in Human Multidrug Resistance Protein 1"Molecular Pharmacology. (印刷中). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wang X., Furukawa T., Nitanda T., Okamo M, Sugimoto Y., Akiyama S., Baba, M.: "Breast cancer resistance protein(BCRP/ABCG2)induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors."Molecular Pharmacology. 63. 65-72 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikeda R., Furukawa T., Mitsuo R., Noguchi T., Kitazono M., Okumura H., Sumizawa T., Haraguchi M., Che X-F., Uchimiya H., Nakajima Y., Ren X-Q., Oiso S., Ituro I., Yamada K., Mukai M., Akiyama S.: "Biochemica.et Biophysica"Research Communication. 301. 358-363 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ren XQ., Furukawa T., Aoki S., Sumizawa T., Haraguchi M., Kobayashi M., Che X-F., Akiyama S.: "Localization of the GSH-dependent photolabiling site of an agosterol A analog on human MRP1"British Journal of Pharmacology. 138. 1553-1561 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mukai M., Che X-F., Furukawa T., Sumizawa T., Aoki S., Ren XQ., Haraguchi M., Sugimoto Y., Takamatsu H., Akiyama S.: "Reversal of the resistance to STI571 in human chronic myelogenous leukemia"Cancer Science. 94. 557-563 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitsuo M., Noguchi T., Nakajimal Y., Aoki S., Ren XQ, Sumizawa T., Haraguchi M., Kobayashi M., Baba M., Nagata Y., Akiyama S., Furukawa T.: "Binding Site(s) on P-glycoprotein for a newly synthesized photoaffinity analog of Agosterol A."Oncology Research. 14. 39-48 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakajima Y., Gotanda T., Uchimiya H., Furukawa T., Haraguchi M., Ikeda R., Sumizawa T., Yoshida H., Akiyama S.: "Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-Deoxy-L-ribose"Cancer Research. 64. 1794-1801 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ren XQ., Furukawa T., Haraguchi M., Sumizawa T., Aoki S., Kobayashi M., Akiyama S.: "The Functions of ABC Signature Sequence in Human Multidrug Resistance Protein 1"Molecular Pharmacology. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi